Comparison

Native Streptomycin/OVA

Item no. LSHB-PR-2000338433-1mg
Manufacturer Life Science Hub
Amount 1 mg
Category
Type Proteins Native
Specific against other
Host Native
Conjugate/Tag Unconjugated, Untagged
Purity >95% by SDS-PAGE
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Available
Additional information - Category
Protein
Storage Conditions
Store at -70°C or -20°C. Avoid repeated freeze/thaw cycles.
Storage Buffer
0.01M PBS(pH7.4)
Background
Streptomycin is an antibiotic produced by soil bacteria of the genus Streptomyces and is active against both gram positive and gram negative bacteria, including species resistant to other antibiotics, eg some streptococci, penicillin resistant staphylococci, and bacteria of the genera Proteus and Pseudomonas. Originally isolated by Selman A. Waksman and Albert Schatz in 1947, streptomycin is effective against tubercle bacilli and is a mainstay of tuberculosis therapy. Because streptomycin resistant tubercle bacilli emerge during treatment, the antibiotic is usually used in combination with one or more of the drugs isoniazid, ethambutol, and aminosalicylic acid. Streptomycin acts by inhibiting protein synthesis and damaging cell membranes in susceptible microorganisms. Possible side effects include injury to the kidneys and nerve damage that can result in dizziness and deafness.
Endotoxin
Not Tested

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close